Home/Compounds/Pharmaceutical Intermediate/(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolane-3,4-diol
C16H22F3N5O4S2
469.5 g/mol
Pharmaceutical IntermediateWarning
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol
CAS163706-58-9EC812-944-8
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is a purine derivative modified with a trifluoropropylsulfanyl group and a methylsulfanylethylamino substituent, commonly used as a pharmaceutical intermediate in the production of active pharmaceutical ingredients.
pharmaceutical intermediateresearch compound for nucleoside analog synthesis
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 163706-58-9
Related Compounds
ReferenceSame Category
Tributylamine (dichloromethylene)bis(phosphonate)
CAS163706-61-4
pharmaceutical intermediate
ReferenceSame Category
Afatinib Impurity I
CAS1637254-93-3
pharmaceutical intermediate
ReferenceSame Category
2'-Deoxyadenosine monohydrate
CAS16373-93-6
pharmaceutical intermediate
ReferenceSame Category
2'-O-(2-Methoxyethyl)-5-methyluridine
CAS163759-49-7
pharmaceutical intermediate
Safety Reference
Warning
H315Causes skin irritation
Identifiers
IUPAC Name
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolane-3,4-diol
InChIKey
ZGVUPMJCZYBIDI-IDTAVKCVSA-N
SMILES
CSCCNC1=C2C(=NC(=N1)SCCC(F)(F)F)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O
Synonyms (11)
- Cangrelor Impurity 2
- Cangrelor Intermediate